These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 29878614

  • 1. Effect of different hepatitis B infection status on the prognosis of active lupus nephritis treated with immunosuppression: a retrospective analysis of 177 patients.
    Fang J, Li W, Tan M, Peng X, Tan Z, Wang W.
    Int J Rheum Dis; 2018 May; 21(5):1060-1067. PubMed ID: 29878614
    [Abstract] [Full Text] [Related]

  • 2. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving immunosuppressive therapy for glomerulonephritis: a retrospective analysis.
    Fang J, Li W, Peng X, Tan Z, Tan M, Zhang C, Wang W, Xu Z, Zhou G.
    Int Urol Nephrol; 2017 Mar; 49(3):475-482. PubMed ID: 28032257
    [Abstract] [Full Text] [Related]

  • 3. Outcomes and risk factors for hepatitis B virus (HBV) reactivation after kidney transplantation in occult HBV carriers.
    Chen GD, Gu JL, Qiu J, Chen LZ.
    Transpl Infect Dis; 2013 Jun; 15(3):300-5. PubMed ID: 23473005
    [Abstract] [Full Text] [Related]

  • 4. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
    Liao YP, Jiang JL, Zou WY, Xu DR, Li J.
    World J Gastroenterol; 2015 Apr 14; 21(14):4284-92. PubMed ID: 25892880
    [Abstract] [Full Text] [Related]

  • 5. Reactivation of hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.
    Nakamura J, Nagashima T, Nagatani K, Yoshio T, Iwamoto M, Minota S.
    Int J Rheum Dis; 2016 May 14; 19(5):470-5. PubMed ID: 24698305
    [Abstract] [Full Text] [Related]

  • 6. Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease.
    Chen FW, Coyle L, Jones BE, Pattullo V.
    Liver Int; 2013 Sep 14; 33(8):1203-10. PubMed ID: 23522150
    [Abstract] [Full Text] [Related]

  • 7. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
    Wu JM, Huang YH, Lee PC, Lin HC, Lee SD.
    J Clin Gastroenterol; 2009 Sep 14; 43(5):496-8. PubMed ID: 19247200
    [Abstract] [Full Text] [Related]

  • 8. Prophylaxis against hepatitis B virus recurrence after liver transplantation: a registry study.
    Shen S, Jiang L, Xiao GQ, Yan LN, Yang JY, Wen TF, Li B, Wang WT, Xu MQ, Wei YG.
    World J Gastroenterol; 2015 Jan 14; 21(2):584-92. PubMed ID: 25593480
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
    Giaccone L, Festuccia M, Marengo A, Resta I, Sorasio R, Pittaluga F, Fiore F, Boccadoro M, Rizzetto M, Bruno B, Marzano A.
    Biol Blood Marrow Transplant; 2010 Jun 14; 16(6):809-17. PubMed ID: 20060484
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B virus DNA in unusual serological profiles of hepatitis B surface antigen-positive sera.
    Chongsrisawat V, Thawornsuk N, Theamboonlers A, Louisirirotchanakul S, Poovorawan Y.
    Viral Immunol; 2006 Jun 14; 19(4):623-9. PubMed ID: 17201657
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience.
    Papadopoulos N, Deutsch M, Manolakopoulos S, Bitsi C, Michalakeas H, Poulakidas H, Tsironi E, Giannouli S, Papatheodoridis GV, Koskinas J, Pectasides D.
    Eur J Gastroenterol Hepatol; 2017 Jan 14; 29(1):56-60. PubMed ID: 27669175
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin.
    Deng L, Song Y, Young KH, Hu S, Ding N, Song W, Li X, Shi Y, Huang H, Liu W, Zheng W, Wang X, Xie Y, Lin N, Tu M, Ping L, Ying Z, Zhang C, Sun Y, Zhu J.
    Oncotarget; 2015 Sep 22; 6(28):25061-73. PubMed ID: 26314957
    [Abstract] [Full Text] [Related]

  • 17. Reevaluation of the effect of lamivudine therapy preoperative to prevent HBV recurrence after liver transplantation.
    Lu AW, Zheng SS, Wu MP, Shen Y, Yang RW.
    Hepatobiliary Pancreat Dis Int; 2008 Aug 22; 7(4):357-61. PubMed ID: 18693169
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience.
    Chang MS, Olsen SK, Pichardo EM, Stiles JB, Rosenthal-Cogan L, Brubaker WD, Guarrera JV, Emond JC, Brown RS.
    Transplantation; 2013 Apr 15; 95(7):960-5. PubMed ID: 23545507
    [Abstract] [Full Text] [Related]

  • 20. Reactivation of hepatitis B virus in hematopoietic stem cell transplant recipients in Japan: efficacy of nucleos(t)ide analogues for prevention and treatment.
    Nakamoto S, Kanda T, Nakaseko C, Sakaida E, Ohwada C, Takeuchi M, Takeda Y, Mimura N, Iseki T, Wu S, Arai M, Imazeki F, Saito K, Shirasawa H, Yokosuka O.
    Int J Mol Sci; 2014 Nov 21; 15(11):21455-67. PubMed ID: 25421241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.